D'Adda, M., Farina, M., Schieppati, F., Borlenghi, E., Bottelli, C., Cerqui, E., . . . Rossi, G. (2019). The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors. Cancer (0008543X), 125(10), 1674-1683.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
D'Adda, Mariella, et al. "The E13a2 BCR‐ABL Transcript Negatively Affects Sustained Deep Molecular Response and the Achievement of Treatment‐free Remission in Patients with Chronic Myeloid Leukemia Who Receive Tyrosine Kinase Inhibitors."
Cancer (0008543X) 125, no. 10 (2019): 1674-1683.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
D'Adda, Mariella, et al. "The E13a2 BCR‐ABL Transcript Negatively Affects Sustained Deep Molecular Response and the Achievement of Treatment‐free Remission in Patients with Chronic Myeloid Leukemia Who Receive Tyrosine Kinase Inhibitors."
Cancer (0008543X), vol. 125, no. 10, 2019, pp. 1674-1683.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.